CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 71 filers reported holding CULLINAN ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $126,836 | -19.1% | 14,009 | -3.9% | 0.00% | – |
| Q2 2023 | $156,783 | +130.5% | 14,571 | +119.1% | 0.00% | – |
| Q1 2023 | $68,030 | +7.2% | 6,650 | +10.6% | 0.00% | – |
| Q4 2022 | $63,458 | -17.6% | 6,015 | 0.0% | 0.00% | – |
| Q3 2022 | $77,000 | +6.9% | 6,015 | +6.6% | 0.00% | – |
| Q2 2022 | $72,000 | +5.9% | 5,644 | -13.4% | 0.00% | – |
| Q1 2022 | $68,000 | -32.7% | 6,519 | 0.0% | 0.00% | – |
| Q4 2021 | $101,000 | -22.3% | 6,519 | +13.5% | 0.00% | – |
| Q3 2021 | $130,000 | +132.1% | 5,744 | +161.7% | 0.00% | – |
| Q2 2021 | $56,000 | 0.0% | 2,195 | +62.0% | 0.00% | – |
| Q1 2021 | $56,000 | – | 1,355 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $82,295,364 | 16.57% |
| CHI Advisors LLC | 3,414,189 | $36,736,673 | 11.15% |
| Nextech Invest Ltd. | 1,221,145 | $13,139,520 | 4.47% |
| BVF INC/IL | 3,196,701 | $34,396,503 | 0.96% |
| Lynx1 Capital Management LP | 115,063 | $1,238,078 | 0.81% |
| TANG CAPITAL MANAGEMENT LLC | 450,000 | $4,842,000 | 0.71% |
| BRAIDWELL LP | 1,908,865 | $20,539,387 | 0.67% |
| Parkman Healthcare Partners LLC | 346,781 | $3,731,364 | 0.65% |
| Boxer Capital, LLC | 1,074,082 | $11,557 | 0.54% |
| Velan Capital Investment Management LP | 50,000 | $538,000 | 0.50% |